Cargando…
Ursodeoxycholic acid augmentation in treatment-refractory schizophrenia: a case report
BACKGROUND: Treatment-resistance is recognized as a significant dilemma in schizophrenia, which has been reported to involve approximately one-third of patients with schizophrenia. CASE PRESENTATION: This case report described a 12-week treatment course for a 39-year-old Persian man with treatment-r...
Autor principal: | |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7460790/ https://www.ncbi.nlm.nih.gov/pubmed/32867840 http://dx.doi.org/10.1186/s13256-020-02484-9 |